Atea Pharmaceuticals Financial Overview
Atea Pharmaceuticals's market cap is currently $251.57M. The company's EPS TTM is $-0.53; its P/E ratio is -1.79; Atea Pharmaceuticals is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.48. See an overview of income statement, balance sheet, and cash flow financials.
